Prevalence of microorganisms resistant to ciprofloxacin isolated in urinary tract infections at University Hospital of Recife/PE

Detalhes bibliográficos
Autor(a) principal: Lima, Dayana Cecília da Silva
Data de Publicação: 2022
Outros Autores: Leite Segundo, Airton Vieira, Branco, Ana Beatriz Paes de Lira, Britto, Rafaella Henrique Sousa de Araújo, Batista, Renata Prohaska, Camara, Rodrigo Siqueira de Arruda, Duarte Neto, José Manoel Wanderley, Wanderley, Maria Carolina de Albuquerque
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/30588
Resumo: Urinary tract infection (UTI) is one of the main causes of medical consultation, second only to respiratory infections. The main etiologic agent is the bacterium Escherichia coli, but other bacteria, such as Klebsiella pneumoniae, Proteus spp., Enterobacter spp., may also be involved. Ciprofloxacin, from the quinolone class, is the drug of choice to treat UTI. It has high absorption capacity, good coverage by gram-negative bacteria and is available both orally and intravenously. However, microbial resistance to this class of drugs has been increasing. The present study aimed to identify, through the CCIH database of the HC-UFPE, the prevalence of ciprofloxacin-resistant microorganisms in patients with UTI. The research was a cross-sectional study on data from patients with UTI from January to December 2019, with CEP approval under CAAE number 20644719.3.3001.8807. The results showed that, of the 301 positive urine cultures, 82 showed resistance to ciprofloxacin. The most prevalent bacterium was E. coli. Most cases of infection affected women, with 193 female patients, 104 men and 4 newborns. Regarding the clinic, nephrology patients were the ones with the most UTIs. Growing resistance to ciprofloxacin may limit effective therapeutic options for treating UTI, and one of the causes is the indiscriminate and abusive use of antimicrobials. To minimize this situation, it is necessary to alert and make the population aware of the dangers and risks of using antimicrobials without a medical prescription and in the wrong way.
id UNIFEI_823f00cd490df5bc5042505c714e770a
oai_identifier_str oai:ojs.pkp.sfu.ca:article/30588
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Prevalence of microorganisms resistant to ciprofloxacin isolated in urinary tract infections at University Hospital of Recife/PE Prevalencia de microorganismos resistentes a la ciprofloxacina aislada en infecciones del tracto urinario en el Hospital Universitario de Recife/PE Prevalência de microrganismos resistentes a ciprofloxacino isolados em infecções do trato urinário em Hospital Universitário de Recife/PE ITUEscherichia coliQuinolonas. ITUEscherichia coliQuinolonas.UTIEscherichia coliQuinolones.Urinary tract infection (UTI) is one of the main causes of medical consultation, second only to respiratory infections. The main etiologic agent is the bacterium Escherichia coli, but other bacteria, such as Klebsiella pneumoniae, Proteus spp., Enterobacter spp., may also be involved. Ciprofloxacin, from the quinolone class, is the drug of choice to treat UTI. It has high absorption capacity, good coverage by gram-negative bacteria and is available both orally and intravenously. However, microbial resistance to this class of drugs has been increasing. The present study aimed to identify, through the CCIH database of the HC-UFPE, the prevalence of ciprofloxacin-resistant microorganisms in patients with UTI. The research was a cross-sectional study on data from patients with UTI from January to December 2019, with CEP approval under CAAE number 20644719.3.3001.8807. The results showed that, of the 301 positive urine cultures, 82 showed resistance to ciprofloxacin. The most prevalent bacterium was E. coli. Most cases of infection affected women, with 193 female patients, 104 men and 4 newborns. Regarding the clinic, nephrology patients were the ones with the most UTIs. Growing resistance to ciprofloxacin may limit effective therapeutic options for treating UTI, and one of the causes is the indiscriminate and abusive use of antimicrobials. To minimize this situation, it is necessary to alert and make the population aware of the dangers and risks of using antimicrobials without a medical prescription and in the wrong way.La infección del tracto urinario (ITU) es una de las principales causas de consulta médica, sólo superada por las infecciones respiratorias. El principal agente etiológico es la bacteria Escherichia coli, pero también pueden estar implicadas otras bacterias, como Klebsiella pneumoniae, Proteus spp., Enterobacter spp. La ciprofloxacina, de la clase de las quinolonas, es el fármaco de elección para tratar la ITU. Tiene alta capacidad de absorción, buena cobertura por bacterias gramnegativas y está disponible tanto por vía oral como intravenosa. Sin embargo, la resistencia microbiana a esta clase de fármacos ha ido en aumento. El presente estudio tuvo como objetivo identificar, a través de la base de datos CCIH del HC-UFPE, la prevalencia de microorganismos resistentes a la ciprofloxacina en pacientes con ITU. La investigación fue un estudio transversal sobre datos de pacientes con ITU de enero a diciembre de 2019, con aprobación del CEP bajo el número CAAE 20644719.3.3001.8807. Los resultados mostraron que, de los 301 urocultivos positivos, 82 mostraron resistencia a la ciprofloxacina. La bacteria más prevalente fue E. coli. La mayoría de los casos de infección afectaron a mujeres, con 193 pacientes mujeres, 104 hombres y 4 recién nacidos. En cuanto a la consulta, los pacientes de nefrología fueron los que más ITU presentaron. La creciente resistencia a la ciprofloxacina puede limitar las opciones terapéuticas efectivas para el tratamiento de la ITU, y una de las causas es el uso indiscriminado y abusivo de antimicrobianos. Para minimizar esta situación, es necesario alertar y concientizar a la población sobre los peligros y riesgos del uso de antimicrobianos sin prescripción médica y de manera incorrecta.A infecção do trato urinário (ITU) é uma das principais causas de consulta médica, ficando atrás apenas das infecções respiratórias. O principal agente etiológico é a bactéria Escherichia coli, mas outras bactérias, como Klebsiella pneumoniae, Proteus spp., Enterobacter spp., também podem estar envolvidas. O ciprofloxacino, da classe das quinolonas, é a droga de escolha para tratar ITU. Possui alta capacidade de absorção, boa cobertura pelas bactérias gram-negativas e tem sua disponibilidade tanto oral quanto intravenosa. Entretanto, a resistência microbiana a essa classe de medicamentos tem sido crescente. O presente estudo objetivou identificar, através do banco de dados da CCIH do HC-UFPE, a prevalência de microrganismos resistentes a ciprofloxacino em pacientes com ITU. A pesquisa foi um estudo de corte transversal sobre dados de pacientes com ITU no período de janeiro a dezembro de 2019, com aprovação do CEP sob Número do CAAE 20644719.3.3001.8807. Os resultados demonstraram que, das 301 uroculturas positivas, 82 apresentaram resistência a ciprofloxacino. A bactéria mais prevalente foi E. coli. A maioria dos casos de infecção acometeu as mulheres, sendo encontradas 193 pacientes do sexo feminino, 104 homens e 4 recém-nascidos. Com relação à clínica, pacientes da nefrologia foram os que mais apresentaram ITU. A crescente resistência a ciprofloxacino pode limitar as opções terapêuticas eficazes para tratamento da ITU, e uma das causas é uso indiscriminado e abusivo dos antimicrobianos. Para minimizar esta situação, é necessário alertar e conscientizar a população para os perigos e riscos de utilizar antimicrobianos sem prescrição médica e de maneira equivocada.Research, Society and Development2022-06-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/3058810.33448/rsd-v11i8.30588Research, Society and Development; Vol. 11 No. 8; e10411830588Research, Society and Development; Vol. 11 Núm. 8; e10411830588Research, Society and Development; v. 11 n. 8; e104118305882525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/30588/26312Copyright (c) 2022 Dayana Cecília da Silva Lima; Airton Vieira Leite Segundo; Ana Beatriz Paes de Lira Branco; Rafaella Henrique Sousa de Araújo Britto; Renata Prohaska Batista; Rodrigo Siqueira de Arruda Camara; José Manoel Wanderley Duarte Neto; Maria Carolina de Albuquerque Wanderleyhttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessLima, Dayana Cecília da Silva Leite Segundo, Airton VieiraBranco, Ana Beatriz Paes de Lira Britto, Rafaella Henrique Sousa de Araújo Batista, Renata ProhaskaCamara, Rodrigo Siqueira de Arruda Duarte Neto, José Manoel Wanderley Wanderley, Maria Carolina de Albuquerque 2022-07-01T13:34:06Zoai:ojs.pkp.sfu.ca:article/30588Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:47:17.452078Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Prevalence of microorganisms resistant to ciprofloxacin isolated in urinary tract infections at University Hospital of Recife/PE
Prevalencia de microorganismos resistentes a la ciprofloxacina aislada en infecciones del tracto urinario en el Hospital Universitario de Recife/PE
Prevalência de microrganismos resistentes a ciprofloxacino isolados em infecções do trato urinário em Hospital Universitário de Recife/PE
title Prevalence of microorganisms resistant to ciprofloxacin isolated in urinary tract infections at University Hospital of Recife/PE
spellingShingle Prevalence of microorganisms resistant to ciprofloxacin isolated in urinary tract infections at University Hospital of Recife/PE
Lima, Dayana Cecília da Silva
ITU
Escherichia coli
Quinolonas.
ITU
Escherichia coli
Quinolonas.
UTI
Escherichia coli
Quinolones.
title_short Prevalence of microorganisms resistant to ciprofloxacin isolated in urinary tract infections at University Hospital of Recife/PE
title_full Prevalence of microorganisms resistant to ciprofloxacin isolated in urinary tract infections at University Hospital of Recife/PE
title_fullStr Prevalence of microorganisms resistant to ciprofloxacin isolated in urinary tract infections at University Hospital of Recife/PE
title_full_unstemmed Prevalence of microorganisms resistant to ciprofloxacin isolated in urinary tract infections at University Hospital of Recife/PE
title_sort Prevalence of microorganisms resistant to ciprofloxacin isolated in urinary tract infections at University Hospital of Recife/PE
author Lima, Dayana Cecília da Silva
author_facet Lima, Dayana Cecília da Silva
Leite Segundo, Airton Vieira
Branco, Ana Beatriz Paes de Lira
Britto, Rafaella Henrique Sousa de Araújo
Batista, Renata Prohaska
Camara, Rodrigo Siqueira de Arruda
Duarte Neto, José Manoel Wanderley
Wanderley, Maria Carolina de Albuquerque
author_role author
author2 Leite Segundo, Airton Vieira
Branco, Ana Beatriz Paes de Lira
Britto, Rafaella Henrique Sousa de Araújo
Batista, Renata Prohaska
Camara, Rodrigo Siqueira de Arruda
Duarte Neto, José Manoel Wanderley
Wanderley, Maria Carolina de Albuquerque
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Lima, Dayana Cecília da Silva
Leite Segundo, Airton Vieira
Branco, Ana Beatriz Paes de Lira
Britto, Rafaella Henrique Sousa de Araújo
Batista, Renata Prohaska
Camara, Rodrigo Siqueira de Arruda
Duarte Neto, José Manoel Wanderley
Wanderley, Maria Carolina de Albuquerque
dc.subject.por.fl_str_mv ITU
Escherichia coli
Quinolonas.
ITU
Escherichia coli
Quinolonas.
UTI
Escherichia coli
Quinolones.
topic ITU
Escherichia coli
Quinolonas.
ITU
Escherichia coli
Quinolonas.
UTI
Escherichia coli
Quinolones.
description Urinary tract infection (UTI) is one of the main causes of medical consultation, second only to respiratory infections. The main etiologic agent is the bacterium Escherichia coli, but other bacteria, such as Klebsiella pneumoniae, Proteus spp., Enterobacter spp., may also be involved. Ciprofloxacin, from the quinolone class, is the drug of choice to treat UTI. It has high absorption capacity, good coverage by gram-negative bacteria and is available both orally and intravenously. However, microbial resistance to this class of drugs has been increasing. The present study aimed to identify, through the CCIH database of the HC-UFPE, the prevalence of ciprofloxacin-resistant microorganisms in patients with UTI. The research was a cross-sectional study on data from patients with UTI from January to December 2019, with CEP approval under CAAE number 20644719.3.3001.8807. The results showed that, of the 301 positive urine cultures, 82 showed resistance to ciprofloxacin. The most prevalent bacterium was E. coli. Most cases of infection affected women, with 193 female patients, 104 men and 4 newborns. Regarding the clinic, nephrology patients were the ones with the most UTIs. Growing resistance to ciprofloxacin may limit effective therapeutic options for treating UTI, and one of the causes is the indiscriminate and abusive use of antimicrobials. To minimize this situation, it is necessary to alert and make the population aware of the dangers and risks of using antimicrobials without a medical prescription and in the wrong way.
publishDate 2022
dc.date.none.fl_str_mv 2022-06-11
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/30588
10.33448/rsd-v11i8.30588
url https://rsdjournal.org/index.php/rsd/article/view/30588
identifier_str_mv 10.33448/rsd-v11i8.30588
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/30588/26312
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 11 No. 8; e10411830588
Research, Society and Development; Vol. 11 Núm. 8; e10411830588
Research, Society and Development; v. 11 n. 8; e10411830588
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052812441419776